John Pinching from PharmaTimes - Journalist Profile

	Profile	Contacts	Recent Articles on Subject
1	John Pinching PharmaTimes Next-gen biopharma company. La Jolla, California biopharmadrugsdevices		Bayer begins inhibitor study treating advanced KRAS-mutated tumours - 8 days ago Leriglitazone meets primary endpoint in pivotal cALD trial - 8 days ago iOnctura achieves new clinical milestones in uveal melanoma therapy - 9 days ago Leriglitazone meets endpoint in trial for cerebral adrenoleukodystrophy - 9 days ago Cellenkos presents promising phase 1b data for CK0804 in myelofibrosis - 10 days ago CatalYm shows potential of visugromab for treating cachexia - 10 days ago Imfinzi receives NICE recommendation for lung cancer treatment - 11 days ago Poolbeg Pharma presents positive results for POLB 001 - 11 days ago Teva’s Ajovy shows positive results in preventing pediatric migraines - 15 days ago NICE endorses Neuraxpharm’s ublituximab for treating MS - 15 days ago Antag Therapeutics secures €80 million in weight loss therapy financing - 17 days ago Everest therapy shows promise in nephropathy trial - 17 days ago KIMMTRAK recommended for funding by NICE for uveal melanoma patients - 18 days ago Orbit Discovery and Evergreen Theragnostics expand research collaboration - 18 days ago OGT launches enhanced genetic profiling panel for CLL - 18 days ago Pharma giants vie for oral GLP-1R approval - 18 days ago New injection offers hope for asthma and COPD attacks - 22 days ago UK grants promising innovative medicine status to CIDP treatment - 22 days ago Rab Prinjha - 23 days ago God bless, Americas! - 25 days ago Boids zone - 25 days ago On message! - 25 days ago Dr Lara Boyd - 25 days ago Mikkel Wandahl Pedersen - 25 days ago Osivax begins phase 2a booster trial for influenza vaccine - about 1 month ago AC immune announces positive trial results for early Parkinson’s treatment - about 1 month ago Microbiotica begins human trials for ulcerative colitis treatment - about 1 month ago Vivolta and Neurochase to produce brain therapy catheters - about 1 month ago SMC recommends Yselty for treating uterine fibroids - about 1 month ago Scottish medicines consortium approves CAR T-cell therapy for blood cancer - about 1 month ago New study to assess mpox vaccine in pregnant women and infants - about 1 month ago Elsevier backs Pistoia Alliance for AI in drug discovery - about 1 month ago Arcellx to present positive data on multiple myeloma treatments - about 1 month ago MHRA grants approval for bladder cancer drug erdafitinib - about 1 month ago Dr Jane Rhodes - about 2 months ago Anthony Hemmerdinger - about 2 months ago Laura Vergani - about 2 months ago NICE recommendation for new Alexion PNH treatment - about 2 months ago Darzalex subcutaneous regimen approved by European Commission - about 2 months ago Calluna Pharma completes successful phase 1 trial of new fibrotic disease drug - about 2 months ago Celltrion unveils promising dose escalation results for subcutaneous infliximab - 2 months ago Alleo and Ubiquigent unite to accelerate drug discovery - 2 months ago Lundbeck to acquire Longboard Pharmaceuticals in strategic deal - 2 months ago Transgene’s cancer vaccine trial shows mixed results - 2 months ago IRLAB’s new drug shows promise in treating apathy in Parkinson’s patients - 3 months ago ERLEADA shows 23% survival benefit over enzalutamide in prostate cancer study - 3 months ago Insilico Medicine reports positive results for idiopathic pulmonary fibrosis therapy - 3 months ago AlzeCure’s ACD856’s effects to be presented at Alzheimer’s conference - 3 months ago EC approves Yuvanci for pulmonary arterial hypertension treatment - 3 months ago Dr Alex Dickinson - 3 months ago